Login or Register to make a submission.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
  • The submission file is in OpenOffice, Microsoft Word, RTF, or PDF document file format.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end. If tables are used, they should be double spaced on separate pages. They should be numbered and cited in the text of the article. If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly.
    Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.

Submissions: Guidelines for Authors

Microscopie publishes
Research articles, Technical reports, Reviews, Letters to the Editor, Views & Comments. Contributions are encouraged from investigators in any country.

Each manuscript should be typewritten, double spaced throughout; pages should be in A4 format and numbered, lines should be left numbered in continuum (10-digit numeric system).

The manuscript should be divided into: Title page; Abstract; Text; Acknowledgments; References; Tables; Figures; Figure legends.

The Title page should contain the following information: Title of the paper (lowercase), without acronyms; initials of the name and full surname of author(s); full name and address of the institution(s) where the work was done; complete address (postal and E-mail address, phone and fax numbers) of the corresponding author; key words (no more than seven); authors' contributions, i.e., information about the contributions of each person named as having participated in the study (http://www.icmje.org/#author); disclosures about potential conflict of interest.

The Abstract (not exceeding 1600 characters, spaces included) must be analytically informative.

The Text should normally be subdivided into: Introduction, Materials and Methods, Results, Discussion. In the Introduction, which should be concise, the purpose of the research must be clearly explained. Materials and Methods should report all information useful for repetition of the experiments. Generic and specific names should be typed in italics. When chemicals are quoted, well defined, registered names should be used following the subject index of chemical abstracts. When the text refers to enzymes, the trivial names should be given as published in Enzyme nomenclature by Academic Press, 1984. Units of measurements should be those recommended by the International Committee for the Standardization of Units of Measurements, please check this site (http://www.bipm.org/en/si/si_brochure) for Uniform Requirements. Results should include the presentation of all experimental data; the description of the original observations must be concise, avoiding the use of both tables and graphs to illustrate the same results. An adequate statistical analysis of quantitative data should be provided. General considerations and conclusions should be reported in the Discussion only.
If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).
If names of equipment or substances are mentioned in the text, brand, company names and locations (city and state) for equipment and substances should be included in parentheses within the text.

Acknowledgments will be placed at the end of the text.

Reference list entries should be alphabetized by the last names of the first author of each work. The list of references should only include works that are cited in the text and that have been published or accepted for publication.
Cite references in the text by name and year in parentheses as follows: (Falcieri, 2014), (Cavallini and Biscarini, 2003; Montone et al., 2007).
References to personal communications and unpublished data should be incorporated in the text and not placed in the reference list [Example: (Wright 2011, unpublished data) or (Wright 2011, personal communication)].

Illustrations. Symbols and abbreviations used in figures can be defined in the figure caption or note or within the figure itself. Please avoid the use of bold face or greater size for the characters. Please remember that in order to promote good management of the space available images must take up the least space possible without compromising clarity.
Figures and graphs must be submitted as .tif or .jpg files, with the following digital resolution at the final printing size (one column width: 8.5 cm; two column width: 17.5 cm): Color (saved as CMYK): minimum 300 dpi Black and white/grays: minimum 600 dpi Lettering of figures must be clearly labelled.
Several figures should be grouped into a plate.
Micrographs contained in the same figure should be marked with letters.
Light and electron micrographs must contain reference scale bars.


The legends of Tables and Figures should be informative and concise without duplicating information presented within the body of the text. Remarks such as “see comments in the text” must be avoided.

Permissions
In case extracts (text/figures/tables) from other copyrighted works are included, the author(s) must obtain written permission from the copyright holder(s) and credit the source(s) in the article, for example: 'Adapted from Costanzo et al., Microscopie 2017;27:66-71; with permission'. The editorial office of Microscopie needs to receive a copy of the WRITTEN PERMISSION before proceeding with publication.


Manuscript will be carefully scrutinized for evidence of plagiarism, duplication and data manipulation; in particular, images will be carefully examined for any indication of intentional improper modification.

Peer-review policy
All manuscripts submitted to our journal are critically assessed by the Editorial Board and by external experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).

Authorship: all persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials): the ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research: When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. An Informed Consent statement is always required from patients involved in any experiments. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.  Further guidance on animal research ethics is available from the World Medical Association (2016 revision) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare. When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.